Mark T. Reding, MD - Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice - a podcast by PVI, PeerView Institute for Medical Education
from 2018-11-12T18:00
::
::
Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice
Further episodes of PeerView Oncology
Further podcasts by PVI, PeerView Institute for Medical Education